Istradefylline 5mg 5mg | Purity Not Available
Adooq Bioscience
Istradefylline (KW-6002) is a selective antagonist at the A2A receptor. It has been found to be useful in the treatment of Parkinson’s disease.
More Information Supplier PageIstradefylline (KW-6002) is a selective antagonist at the A2A receptor. It has been found to be useful in the treatment of Parkinson’s disease.
More Information Supplier PageIstradefylline (KW-6002) is a selective antagonist at the A2A receptor. It has been found to be useful in the treatment of Parkinson’s disease.
More Information Supplier PageIstradefylline (KW-6002) is a selective antagonist at the A2A receptor. It has been found to be useful in the treatment of Parkinson’s disease.
More Information Supplier PageGSK-525762A is a small molecule inhibitor of the BET (Bromodomain and Extra-Terminal) family
More Information Supplier PageGSK-525762A is a small molecule inhibitor of the BET (Bromodomain and Extra-Terminal) family
More Information Supplier PageGSK-525762A is a small molecule inhibitor of the BET (Bromodomain and Extra-Terminal) family
More Information Supplier PageGNF 2 is a Bcr-abl inhibitor that inhibits proliferation and induces apoptosis in Bcr-abl-expressing cells.
More Information Supplier PageGNF 2 is a Bcr-abl inhibitor that inhibits proliferation and induces apoptosis in Bcr-abl-expressing cells.
More Information Supplier PageGNF 2 is a Bcr-abl inhibitor that inhibits proliferation and induces apoptosis in Bcr-abl-expressing cells.
More Information Supplier Page